Profile for Serbia Patent: 62846
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Serbia Patent: 62846
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jul 2, 2034 | Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
| ⤷ Start Trial | Jul 2, 2034 | Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
| ⤷ Start Trial | Jul 2, 2034 | Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
| ⤷ Start Trial | Jul 2, 2034 | Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
